U.S. Preeclampsia Market Size & Outlook, 2025-2033
Related Markets
U.S. preeclampsia market highlights
- The U.S. preeclampsia market generated a revenue of USD 452.8 million in 2024 and is expected to reach USD 994.6 million by 2033.
- The U.S. market is expected to grow at a CAGR of 9.2% from 2025 to 2033.
- In terms of segment, blood tests was the largest revenue generating test type in 2024.
- Blood Tests is the most lucrative test type segment registering the fastest growth during the forecast period.
Preeclampsia market data book summary
| Market revenue in 2024 | USD 452.8 million |
| Market revenue in 2033 | USD 994.6 million |
| Growth rate | 9.2% (CAGR from 2025 to 2033) |
| Largest segment | Blood tests |
| Fastest growing segment | Blood Tests |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood Tests, Urinalysis |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.1% of the global preeclampsia market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. preeclampsia market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 88.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preeclampsia Market Scope
Preeclampsia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| mProbe | View profile | 11-50 | Palo Alto, California, United States, North America | https://mprobe.com |
| Metabolomic Diagnostics | View profile | 11-50 | Cork, Cork, Ireland, Europe | http://metabolomicdiagnostics.com |
| DiabetOmics | View profile | 11-50 | Beaverton, Oregon, United States, North America | http://diabetomics.com |
| Thermo Fisher Scientific Inc. | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Sera Prognostics | View profile | 51-100 | Salt Lake City, Utah, United States, North America | http://www.seraprognostics.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Revvity Inc | View profile | 11500 | 940 Winter Street, Waltham, MA, United States, 02451 | https://www.revvity.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
U.S. preeclampsia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preeclampsia market will help companies and investors design strategic landscapes.
Blood tests was the largest segment with a revenue share of 64.16% in 2024. Horizon Databook has segmented the U.S. preeclampsia market based on blood tests, urinalysis covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to U.S. preeclampsia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. preeclampsia market databook
-
Our clientele includes a mix of preeclampsia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. preeclampsia market , including forecasts for subscribers. This country databook contains high-level insights into U.S. preeclampsia market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
US Test Type - Preeclampsia Market size, 2024 - 2033 (US$M)
U.S. Preeclampsia Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
